Shanghai Haohai Announces Key Corporate Governance Changes

An update from Shanghai Haohai Biological Technology Co., Ltd. Class H ( (HK:6826) ) is now available.

Shanghai Haohai Biological Technology Co., Ltd. has announced a change in its corporate governance team. Mr. Chiu Ming King has resigned from his roles as Joint Company Secretary, Authorized Representative, and Process Agent, effective December 12, 2025. He will be succeeded by Ms. Lai Ying Tung, who brings nearly a decade of experience in corporate secretarial services and holds a master’s degree in Corporate Governance. The company expressed gratitude to Mr. Chiu for his contributions and welcomed Ms. Lai to her new roles.

The most recent analyst rating on (HK:6826) stock is a Buy with a HK$30.00 price target. To see the full list of analyst forecasts on Shanghai Haohai Biological Technology Co., Ltd. Class H stock, see the HK:6826 Stock Forecast page.

More about Shanghai Haohai Biological Technology Co., Ltd. Class H

Average Trading Volume: 245,912

Technical Sentiment Signal: Sell

Current Market Cap: HK$11.14B

See more data about 6826 stock on TipRanks’ Stock Analysis page.